TORONTO, Dec. 7, 2010 /PRNewswire/ — Millennium Research Group
(MRG), the global authority on medical technology market
intelligence, will soon release their latest data on the US clot
management device market.  

MRG’s US Markets for Clot Management Devices 2011 report
provides important insight into the device-based treatments of deep
vein thrombosis and the complex competitive dynamics of medical
device manufacturers in this field. The report also provides market
analyses for devices that treat arteriovenous, peripheral artery,
coronary, and neurovascular thrombosis, including five-year
forecasts, up-to-date market shares, and in-depth qualitative
insights.  Market analysis is provided for product segments
including thrombectomy devices, thrombolytic infusion catheters,
inferior vena cava filters, and neurovascular embolectomy devices.
 

“We were able to leverage the results of the physician survey
that we conducted this year—Venous Interventions:
  The Rise of Venous Stenting and Aggressive Deep-Vein
Thrombosis Treatment—to gather additional insight on how
physicians expect their use of the different device-based
treatments to change over the forecast period,” says Stephanie
LaBelle, Manager of the Cardiovascular division at MRG.  “A
lack of awareness among referring physicians is a major roadblock
to increasing the number of interventions in the venous system.
However, more facilities are beginning to implement screening
processes for high-risk deep-vein thrombosis patients, and
awareness of newer treatment options is growing.  The use of
pharmacomechanical thrombectomy systems for deep vein thrombosis
removal is gaining a lot of attention and, as a result, we expect
to see high growth in this segment of the market through 2015.”

MRG’s clot management device report series also includes
coverage of Europe.  Please contact Amy Krohn at 416-364-7776
ext. 101 or

SOURCE